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The National Toxicology Program (NTP)
has broad responsibilities for: 1) expanding
the toxicology database on the impact of
chemical interactions with biological sys-
tems; 2) providing data that strengthen the
science base for regulatory decisions; 3)
developing and validating alternative test
systems; and 4) communicating strategies
and findings to the scientific community,
regulatory agencies, and the public. To
meet these responsibilities, NTP strategies
and approaches are evolving along a num-
ber offronts. The overall objective ofthese
initiatives is to more efficiently test chemi-
cals for toxic effects using a broad array of
test systems and to generate data that
strengthen the scientific foundation on
which risk assessments are based. To devel-
op strategies to improve the ability to meet
these goals, the NIEHS/NTP sponsored
the Workshop on Mechanism-based
Toxicology in Cancer Risk Assessment:
Implications for Research, Regulation, and
Legislation, held 11-13 January 1995 in
Research Triangle Park, North Carolina.
Recent legislative and government acts
and authorities have called for improvements
in risk assessment and prevention strategies.
Moreover, the 1992 Advisory Review report
ofthe NTP Board emphasized the need for
more mechanism-based studies, and there
has been increasing emphasis by NTP scien-
tists over the past few years in incorporating
mechanistic considerations in studies. The
need to develop approaches for using mecha-
nistic information in toxicological evalua-
tions is emphasized by the fact that of the
70,000 chemicals currently in commerce,
adequate toxicological data are available for
only 10-20%. Although traditional toxicity
tests such as the two-year rodent bioassay
have been the basis for most regulatory deci-
sions regarding the safety of environmental
chemicals, only a limited number ofchemi-
cals can be studied bythis approach. Current
risk assessment approaches frequently use
default assumptions which reflect an inade-
quate scientific foundation for assessing risk.
While good epidemiology studies are desir-
able, they are relatively insensitive and tend
to detect an effect that has already occurred;
toxicology, mechanistic, structure activity,
and predictive toxicology studies can be part
of a prevention strategy. Thus, the crux of
the problem is at least twofold: how can ade-
quate toxicology information be developed
on more chemicals ofpublic health impor-
tance while at the same time providing data
for strengthening the scientific foundation
and reducing the uncertainty in deriving
human risk estimates. Increased knowledge
ofmechanisms canhelp in severalways.
An evolving NTP program in mecha-
nism-based toxicology could draw on the
tools ofmolecular biology, which can char-
acterize interactions ofchemicals with criti-
cal target genes, to provideviable approach-
es for the development of more accurate
and inexpensive methods to perform not
only the first step in risk assessment (i.e.,
hazard identification), but also contribute
to determining quantitative dose-response
relationships and establishing biomarkers
for estimatinghuman exposure.
The NTP is attempting to integrate
mechanistic data, human data, toxicity test
data, and biomathematics to develop
methods for strengthening the scientific
foundation on which risk assessments are
based. Resources from throughout the
institute and participating agencies are
being drawn together to accomplish these
new initiatives. This process is just begin-




The overall goals ofthe workshop were to
1) assess the scientific foundation for using
mechanism-based toxicology to address
critical issues in risk assessment, 2) identify
and propose solutions to the regulatory
problems that may emerge by the use of
mechanistic toxicology in conducting risk
assessments, and 3) determine the applica-
bility of mechanism-based toxicology in
conducting risk assessment to current leg-
islative issues. The workshop included the
needs, views, and issues offederal and state
regulatory agencies, industry, labor, envi-
ronmental organizations, the legislative
branch, the broader scientific community,
and thepublic.
The strutcture of the workshop includ-
ed a plenary session in which leading fig-
ures in the scientific and regulatory com-
munities defined the issues. (Plenary
speakers are listed in the box insert.)
The workshop centered around five
different work groups, reflecting five uses
ofmechanistic toxicology: screening chem-
icals and setting priorities for carcinogen
testing; hazard identification; determining
dose-response relationships; species extrap-
olation; and determining distributions of
risk based on genetic predisposition, age,
gender, nutrition, and other factors. Work
groups were asked to develop recommenda-
tions and to identify areas ofconsensus, dis-
agreement, and knowledge gaps and how to
address those gaps.
Each work group consisted of two co-
chairs, a rapporteur, and approximately
10-12 other invited participants. In addi-
tion, there were 20-30 observers in each
group who participated in the meeting.
Overali Recommendations
There were several recommendations that
were developed during the course of the
workshop. There were extensive discussions
on these recommendations at the final ple-
nary session and in the public comment ses-
sionwhich followed. Workshop recommen-
dations will help the NTP set research pri-
orities and will also help make more effec-
tive links between science and policy. If
implemented, the recommendations will
strengthen the scientific foundation on
which risk assessments are based and will
address some of the concerns that have
spawned recent risk assessment legislation.
The recommendations dearly state that the
NTP should become more active in devel-
oping approaches to generate scientific data
to reduce uncertainty in risk assessments. A
number of overall recommendations were
consistently expressed during the plenary
sessions, public comments, and work group
deliberations:
* Mechanistic and risk assessment con-
siderations should be incorporated into
experimental design and data analysis. Such
considerations also should be used in the
selection of chemicals to be evaluated for
carcinogenicity bythe NTP.
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The complete work group proceedings are available
from the NTP Liaison Office, NIEHS, PO Box
12233, Research Triangle Park, NC 27709 (FAX:
919-541-0295). This report will help guide the
NTP's research priorities in the coming years and
will also help in solving the.problems encountered
by regulatory agencies in using mechanistic infor-
mation in risk assessment.
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* Uncertainty factors in risk assessment
should be a critical feature in experimental
design, especially interindividual variation,
dose-response relationships, and species
extrapolation.
* Less expensive, faster, and more accu-
rate methods for setting priorities and pro-
viding toxicological evaluations need to be
developed and validated. These methods
would range from in vitro methods to
modified in vivo approaches, including
transgenics.
* Experimental models for evaluating
agents or classes ofagents should be select-
ed by considering the knowledge gaps that
need to be filled for that agent or class of
agents.
* The NTP should continue, for the
foreseeable future, long-term bioassays,
which provide valuable information. NTP
and regulatory reliance on long-term bioas-
says should only be diminished when alter-
native methods are appropriately validated.
* The acquisition of molecular and
biochemical data from exposed popula-
tions is critical for risk assessment. The
NTP should improve the linkage between
experimental toxicology and molecular
epidemiology as part ofthe process ofpro-
viding toxicological evaluations of public
health interest.
* The NTP, working closely with stake-
holders, should develop guidelines for
achieving regulatory acceptance of mecha-
nistic information in risk assessment. These
guidelines should be flexible in order to
accommodate the wide variety of mecha-
nisms likely involved in chemical carcino-
genesis, the recognition that knowledge of
mechanisms will never be complete, and the
continued evolution ofscientific knowledge.
* The NTP should play a more active
role in coordinating overall approaches to
incorporate mechanistic information in risk
assessment, including sponsoring work-
shops on specific topics.
* Effective communications with all
stakeholders including industry, unions,
environmental groups, legislators, and sci-
entists will be essential in attempts to
improve the credibility ofrisk assessment.
Individual Work Groups and
Recommendations
Screening Chemicals and Setting
Priorities for Carcinogen Testing
The focus of this group was on strategies
for developing rational approaches for
identifying agents that should be further
evaluated and for testing classes of chemi-
cals that share common structural or bio-
logical properties. Alternative or flexible
designs of bioassays that could affect the
understanding of the hazards of a series of
chemicals were an important aspect ofthis
discussion group. Topics discussed includ-
ed alternative test systems, types ofmecha-
nistic endpoints most useful in predictive
toxicology, validation of short-term tests,
and evaluation ofmixtures. The group also
discussed communication strategies that are
needed to achieve regulatory acceptance of
alternative methods and the need to involve
all stakeholders in developing strategies for
using mechanistic information in priority
setting.
Recommendations. The establishment of
a peer-reviewed document is recommended
to form the basis for predicting outcomes of
rodent bioassays. This document would
include: 1) synthesis ofall experimental data
that indicate that the agent is very likely to
prove carcinogenic to rodents, unlikely to be
carcinogenic, or gives mixed signals of car-
cinogenic potential, 2) if likely to be car-
cinogenic, how the activity could be most
readily assessed/ defined (strain/species,
etc.), 3) if carcinogenic in a chronic bioas-
say, do the predictive and mechanistic data
indicate a probable commensurate hazard to
humans or arodent-specific effect?
The NTP should develop categories of
mechanistic endpoints to evaluate environ-
mental agents with the standard bioassay.
In this manner NTP can validate the pre-
dictive nature of mechanistic/short-term
studies. Until this method is validated and
accepted by all concerned parties, there
should be no diminution ofbioassays.
The NTP should embark on an educa-
tional campaign. The purpose of this edu-
cational campaign would be to develop sci-
entific consensus, broaden current thinking
as to what is necessary to determine car-
cinogenicity, and deal with the problems
posed by legal precedents. The NTP should
explore a partnership with International
Agency for Research on Cancer, EPA, and
other interested entities to accomplish this
educational goal.
Carcinogen Hazard Identification
Strategies for identifying or predicting
chemicals reasonably anticipated to be car-
cinogenic to humans in the absence oftwo-
year rodent bioassays were addressed in this
work group. The type and extent of data
necessary (for example, structure activity,
genotoxicity, receptor-mediated effects, and
other biological activities) to predict and
classify a chemical as potentially hazardous
were discussed. The intent is to identify
potential carcinogens on the basis ofmecha-
nisms or to provide strong evidence predict-
ing a negative response. The extent to which
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this information can be used for setting pri-
orities for further studies and for regulatory
actions was akey point in the discussion.
Recommendations. Although the
emphasis on long-term bioassays to assess
carcinogenic potential in experimental ani-
mals should not be diminished, long-term
studies should not be conducted when
alternative data suggest little need to con-
duct a bioassay to address the question of
hazard identification.
The NTP is evaluating transgenic mice
with an activated Ha-ras gene and those in
which a single copy of the p53 gene has
been inactivated. The results ofthese stud-
ies are promising, and further studies,
including validation and the creation of
mice with other targeted genes, may merit
consideration.
Predicting carcinogenic potential is an
analytical process that requires significant
scientific judgment and should be done on
an ad hoc, case-by-case basis. Characteri-
zation ofan agent as "likely" or "not likely"
to be a carcinogen based on mechanistic
information should be accompanied by a
statement detailing 1) the basis for the classi-
fication, 2) the degree of confidence in the
prediction (low, medium, or high, for exam-
ple), 3) the mechanistic relevance ofthe data
from a particular assay or study used in the
assessment, 4) the degree ofvalidation ofthe
approaches used, 5) the empirical predictive
power of each assay or study used, and 6)
the consistency ofresponses across all ofthe
endpoints evaluated.
The NTP and other groups should be
encouraged to continue to pursue the
development ofalternative, mechanistically
based methods for predicting carcinogenic-
ity. As part ofthe development process, the
NTP, possibly together with other national
and international institutes, should orga-
nize approach (assay)-specific workshops so
that promising areas ofresearch can be dis-
cussed in depth for their utility, limita-
tions, and needs. Examples of promising
approaches discussed that may warrant a
workshop are: development and use of
transgenic mice (genes include cancer
genes, genes involved in metabolism, and
bacterial reporter genes such as lac), struc-
ture-activity relationships, cell transforma-
tion (including human cells), and molecu-
lar data from exposed human populations
(this area is currently underrepresented by
the NTP, but may be a rich source of
mechanisms on human carcinogenesis).
Determining Dose-Response
Relationships for Chemical Effects
and Low-Dose Extrapolation
This group discussed the use ofmechanisti-
cally important endpoints other than
tumor formation for determining
dose-response relationships and low-dose
extrapolation and the impact of this
approach to risk assessment. The kinds of
data most useful for low dose risk estimates
were evaluated in relation to availability of
comparable data in humans. Experimental
and mathematical approaches to dose-effect
relationships and the data necessary to pre-
dict tumor responses from mechanistic-
based endpoints within the framework of
multistage models were addressed. Ofpar-
ticular interest is the development ofcredi-
ble strategies for the NTP to provide data
more usable for low-dose risk estimates.
Recommendations. Definition of a
mode of action is critical to establishing a
mechanistically based dose-response curve.
Mode of action is defined as one or more
obligatory steps in a carcinogenic process
such as interaction ofa chemical with a cel-
lular receptor. Mechanism ofaction implies
a more complex description of the myriad
primary and secondary effects, interactions,
and alterations that occur in chemical car-
cinogenesis. Establishment of either com-
parable evidence or plausibility based on
data for related compounds for the mode
of action in both rodents and humans (or
human tissues) is critical for interspecies
extrapolation and dose-response modeling.
The NTP should make an effort to
develop methods for measuring biochemi-
cal, cellular, and molecular endpoints in
both rodents and humans to aid in the
extrapolation of risks across the two
species. Where possible, these measure-
ments should also be obtained in humans
concurrent with rodent assays. Thought
should be given to the establishment of
databases for these endpoints in both
humans and animals (especially in untreat-
ed cohorts) to aid in assessing interindivid-
ual variability.
The NTP should consider routinely
incorporating changes in the bioassay
design to address unanswered questions that
lead to uncertainties in dose-response eval-
uation, including the collection of mecha-
nistic data from the 90-day subchronic
studies. Multitime, multidose studies may
be conducted to provide additional infor-
mation on pathogenesis in relation to dose.
As much data as possible should be
routinely collected at the individual animal
level, and these data should be available to
the scientific community. This would help
in evaluating dose response, describing the
full range ofexpected risks, and in identify-
ing molecular or biological endpoints most
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predictive of risk. Endpoints such as cell
proliferation, mutations of critical target
genes, and altered expression of target
genes might be especially useful.
The NTP should develop methods and
data to provide a better link than adminis-
tered dose between the chronic study for
cancer and the short-term studies. These
studies may require significant extensions
of the dose-response range to accommo-
date mechanistic data.
Support for research on mode ofaction
should be hypothesis-driven, using struc-
ture-activity relationships and other pre-
dictive measures to maximize the genera-
tion ofusable data. Regulatory data-gather-
ing schemes should provide incentives for
the generation of quantitative data that
expedite and improve regulatory decisions.
Guidelines should be developed to create
a framework for acceptance of mechanistic
approaches that override current default
positions for estimating dose-response rela-
tionships, although in the absence ofmecha-
nistic data, regulatory agencies may be
forced to use certain default positions to
evaluate risk under tight time constraints.
Statistical and mathematical procedures for
handling these data and characterizing mod-
els should be developed and implemented.
Ad hoc, quantitative descriptions of
response without concern for statistical con-
siderations should be avoided.
Species Extrapolation
Given that mechanisms ofaction are never
completely understood, how can current
advances in mechanisms ofaction ofchem-
icals be used to predict responses in differ-
ent species for different classes of chemi-
cals? What chemical classes are currently
understood sufficiently to allow this analy-
sis? What additional classes need to be
studied? How does one deal with the situa-
tion where a chemical exhibits multiple
mechanisms? What constitutes a sufficient
body ofevidence that a tumor is related to
a mechanism with little relevance to
humans, or how can knowledge ofmecha-
nism be used to strengthen the use of ani-
mal data for estimating human risks? Can a
general research strategy or approach be
developed that can direct necessary research
to support mechanistic arguments and bet-
ter link science to risk assessment?
Recommendations. Mechanistic data can
be used initially in a qualitative determina-
tion of the biological relevance of a rodent
bioassay for estimating human risks. This
determination may suggest that it is not
appropriate to infer a cross-species cancer
risk, and risk assessment should not be pur-
sued for this particular finding. However,
simply demonstrating that a mechanism
found in a rodent strain does not exist in
humans is not sufficient; the mechanism
must be demonstrated to be involved in pro-
ducing tumors in rodents.
The NTP should identify bioassays
where significant species differences or sim-
ilarities in response exist to help the scien-
tific community focus efforts to validate
proposed biomarkers, further establish can-
cer mechanisms, and enhance understand-
ing of interspecies extrapolations. In the
validation of new mechanism-based meth-
ods for toxicology and carcinogenicity
studies, the NTP should not limit compar-
isons of new methods with data from
established rodent models, but should also
consider existing data relating to recog-
nized human risks.
Compounds with positive results in val-
idated mechanistic studies can be reason-
ably expected to be potentially carcino-
genic. This determination should be made
on a weight-of-the-evidence basis, and may
support the following decisions: 1) qualita-
tive hazard identification and appropriate
interventions to reduce exposures, 2) prior-
itization of substances for further testing,
including the rodent bioassay, 3) classifica-
tion decisions, in which case classification
rules may need to be modified so that
appropriate mechanistic information can
be used, and 4) quantitative risk assessment
(with information on dose response from
mechanistic studies and pharmacokinetic
data).
Distributions ofRisk
Individuals (humans and rodents) vary
greatly in their responses to chemically
induced toxicity. Given this fact, current
risk assessment methods assume that the
most susceptible rodent represents the most
susceptible human. This assumption could
overestimate or underestimate risks to
humans. Given the recent advances in
identifying the basis ofgenetic susceptibili-
ties for chemicals in humans and rodents as
well as age and gender-dependent differ-
ences, how can we design experiments to
determine the distribution of risks among
different populations? Another topic was
the use ofmechanistic approaches to more
accurately determine exposure so that more
accurate assessments of gene/environment
interactions can be made.
Recommendations. The NTP should
take an active role in coordinating research
on gene/environment interactions to
improve understanding of the range of
risks expected in general or worker popula-
tions as a consequence of chemical expo-
sures. When possible, risk assessment mod-
els should take into account human bio-
marker validation and individual misclassi-
fication issues. False positive and negative
results have major social, economic, and
emotional consequences for those misclas-
sified individuals. These issues are critical
topics for future workshops by NTP.
The acquisition and use of data that
will be acquired over the next decade will
require building trust among community,
scientific, regulatory, industrial, occupa-
tional, and at-risk constituencies. At the
present time, this trust is generally lacking;
as researchers move from population-based
to individual-based risk assessment strate-
gies, outreach to build this trust becomes
more important. The NTP should take an
active role in bringing together representa-
tives from these various constituencies to
discuss these issues.
The NTP should take a leadership role
in coordinating and developing approaches
to maximize the use of biomarkers in ani-
mal models and in human samples to better
understand distribution ofrisk. Research at
all levels relevant to the distribution ofrisk,
including genetic predisposition, age, gen-
der, and nutrition, should be considered.
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Work Group Members
Screening Chemicals and Setting
Priorities for Carcinogen Testing
JohnWalker, U.S. Environmental
Protection Agency
Sidney Green, U.S. Food and Drug
Administration
JerryWard, National Cancer Institute
Lauren Zeise, California Environmental
Protection Agency
Harri Vainio, Finnish Institute of
Occupational Health
Curtis Klaasen, University ofKansas
Medical School
Hank Gardner, U.S. Army Biomedical
Research and Development Laboratories
Bryan Hardin, National Institute for
Occupational Safety and Health
Paul Nettesheim, National Institute of
Environmental Heath Sciences
Peter Defur, Environmental Defense Fund
William Stokes, National Institute of
Environmental Health Sciences
Richard Hill, U.S. Environmental
Protection Agency
Carcinogen Hazard Identification
Douglas McGregor, International Agency
for Research on Cancer
Stephen Nesnow, U.S. Environmental
Protection Agency
Loretta Schuman, Occupational Safety and
Health Administration
Samuel Cohen, University ofNebraska
Medical Center
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John Moore, Institute for Evaluating
Health Risks
Arnold Brown, University ofWisconsin
Medical School
James Huff, National Institute of
Environmental Health Sciences
Tracie Bunton, Johns Hopkins University
David Hoel, Medical University ofSouth
Carolina
JackTaylor, National Institute of
Environmental Health Sciences




Errol Zeiger, National Institute of
Environmental Health Sciences
Determining Dose-Response
Relationships for Chemical Effects and
Low-Dose Extrapolation
George Lucier, National Institute of
Environmental Health Sciences
Suresh Moolgavkar, Fred Hutchinson
Cancer Center
John Bailer, Miami University ofOhio
Ronald Lorentzen, U.S. Food and Drug
Administration
John Vandenberg, U.S. Environmental
Protection Agency
David Gaylor, National Center for
Toxicological Research
Beth Mileson, State ofNorth Carolina
Division ofEnvironmental Management
Bailus Walker, Howard University College
ofMedicine
Rogene Henderson, Inhalation Toxicology
Research Institute
Kenny Crump, ICF Kaiser
Byron Butterworth, Chemical Industry
Institute ofToxicology
Species Extrapolation
James Bond, Chemical Industry Institute
ofToxicology
Gary Boorman, National Institute of
Environmental Health Sciences
Melvin Andersen, ICF Kaiser
Val Schaeffer, U.S. Consumer Product
Safety Commission
Paulo Toniolo, NewYork University
Medical Center
Ronald Melnick, National Institute of
Environmental Health Sciences
H.B. Matthews, National Institute of
Environmental Health Sciences
HenryAnderson, Wisconsin Bureau of
Public Health
David Dankovic, National Institute for
Occupational Safety and Health
Determining Distributions ofRisk
Roger McClellan, Chemical Industry
Institute ofToxicology
Eula Bingham, University ofCincinnati
Jeffrey Boyd, University ofPennsylvania
Medical Center
Christopher DeRosa, Agency forToxic
Substances and Disease Registry
Adam Finkel
Kenneth Rudo, NC Department of
Environmental Health and Natural
Resources
Peter Infante, Occupational Safety and
Health Administration
Ainsley Weston, Mount Sinai Medical
Center
John Ruffin, National Institutes ofHealth
Office ofResearch on Minority Health
Carrie Hunter, National Institutes of
Health Office ofResearch on Women's
Health
Leslie Stayner, National Institute for
Occupational Safety and Health
James Walker, U.S. Environmental
Protection Agency
ISSX 1996 European Spring Workshop
Food Toxins and Host Mechanisms
Conditioning Toxic Responses
Sitges, Spain June 1-4, 1996
This European ISSX Workshop will take place Saturday, June I-Tuesday, June 4 in the lovely seashore city ofSitges,
located 30 km south of Barcelona. Workshop attendance will be limited.
The objective ofthe workshop is to bring together both senior and young scientists to present and discuss their latest
contributions in diverse areas of host mechanisms, such as mechanisms oftoxicity, role of biotransformation enzymes,
and inhibitory and inducing effects which condition the response ofxenobiotics. There will be particular emphasis on
compounds present in diet. In addition to the opportunity for poster and oral presentations, the following subjects will
be covered in scientific sessions:
* mechanisms oftoxicity * inhibitory and inducing effects
* role of biotransformation enzymes * natural and artificial food toxins
Local Organizing Committee For further information please contact:
Angel Messenguer, CID, CSIC, Barcelona (Chairman) Prof Angel Messeguer
Josefina Casas, CID, CSIC, Barcelona Department ofBiological Organic Chemistry, CID (CSIC)
Maria-Jose Gomez-Lechon, Hospital "La Fe" Valencia J. Girona, 19. 08034 Barcelona, Spain
Margarita G. Ladona, IMIM Barcelona Telephone: (34) -34006121
Antonio Martinez-Tobed, Lob. Almirrall Barcelona FAX: (34)-3-2045904 E-mail: issx96@cidcsices
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